Гематология / лейкозы / лимфомы

Витамин С может улучшить выживаемость при высоком риске развития лейкоза

Витамин С может улучшить выживаемость при высоком риске развития лейкоза Medvestnik

CELMoDs After T-Cell–Engaging Therapy in Multiple Myeloma

Iberdomide-Based Treatment in Lenalidomide-Refractory Multiple Myeloma

Screening for CHIP Mutations to Guide CAR T Cell Candidacy in Lymphoma

Gene that drives blood cancer drug resistance uncovered with new CRISPR activation tool

Researchers have uncovered a previously unknown gene that causes resistance to a leading blood cancer drug, as well as several genes that accelerate lymphoma growth, using a powerful new CRISPR activation library.

Screening method identifies leukemia drug candidates from more than 4 million compounds

A cancer cell behaves differently from a healthy cell, with unique features that enable rapid growth and bypass quality controls. Rice University's Natasha Kirienko is interested in finding these unique features and exploiting them to advance cancer treatments. In a paper recently published in the journal Leukemia…

NCCN Guidelines Strengthen MRD Testing Recommendations in Multiple Myeloma

SOHO 2026: Disparities, Efficacy, and Long-Term Safety in B-Cell Lymphoma

Sylvester Comprehensive Cancer Center Researchers Discover Why Some Lymphomas Resist CAR T-cell Treatment

Sylvester Comprehensive Cancer Center Researchers Discover Why Some Lymphomas Resist CAR T-cell Treatment University of Miami

Navigating Transplant Strategy for Partial Responders in T-Cell Lymphoma

SOHO 2026: Novel Frontline Strategies and Molecular Approaches in Lymphoma

Sequencing Therapy in Follicular Lymphoma: Making Goal-Oriented Conversations Routine

SOHO 2026: Key Updates Across the Multiple Myeloma Continuum

IASO208 Receives FDA IND Clearance for Relapsed/Refractory B-Cell Lymphoma

Maintaining Quality of Life During Relapsed/Refractory Multiple Myeloma Treatment